Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (16338)	10/10/2003 9:19:52 PM
From: Cacaito	Read Replies (2) \| Respond to of 17367

Mlnm #1 strike, by the way the CAB-2 always the hopeful one, not the halted one. It is a tough case anyway. The adventure cost xoma $6M, not bad, they could have done a whole bpi acne phase I/II and III with that money. $6M so far, they got out of $20 millions, they still pending another $20 millions for mlnm coffers. It is so nice that they make it look like mlnm is the one paying, but the Rap future profits are the payers aka the sharenothings. No wonder the stock does not move, I could understand Dna asking for their money, but mlnm!!! They could advance ING-1 for that money (maybe, it tells the story of how much they love their pipeline). Sad...sad...sad !!! They could buy some small private biotech with that money, or they could just use it for the annual report to decrease opperating losses. Or they could talk to Biogen, MDCO got Angiomax, look at Tanox with nice Hiv drug, Dna is fishing in their lymph B technology, plenty more at Biogen, even better Biogen/Idec!!! They could talk to Serono for candidates!